D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Humana
HUM
$46.7B
| $10.8M | 0.02% |
44,492
-4,354
| -9% | -$1.07M |
|
877
Adient
ADNT
$1.6B
| $10.8M | 0.02% |
128,679
+72,780
| +130% | +$5.16M |
|
|
KITE
878
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $10.8M | 0.02% |
60,000
| – | – |
|
879
Restaurant Brands International
QSR
$25.1B
| $10.7M | 0.02% |
168,139
+46,731
| +38% | +$2.89M |
|
|
QUOT
880
DELISTED
Quotient Technology Inc
QUOT
| $10.7M | 0.02% |
685,828
-3,617
| -0.5% | -$49.9K |
|
881
PUT
Trip.com Group
TCOM
$27.5B
| $10.7M | 0.02% |
203,400
+3,400
| +2% | +$185K |
|
882
Central Garden & Pet Co Class A
CENTA
$2.41B
| $10.7M | 0.02% |
360,530
-20,763
| -5% | -$550K |
|
883
SITE Centers
SITC
$230M
| $10.7M | 0.02% |
908,095
-602,754
| -40% | -$7.55M |
|
|
COWN
884
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $10.7M | 0.02% |
601,997
+31,947
| +6% | +$523K |
|
885
PUT
Under Armour
UAA
$3B
| $10.7M | 0.02% |
650,000
+113,600
| +21% | +$2.09M |
|
886
PUT
Transocean
RIG
$5.92B
| $10.7M | 0.02% |
993,200
+678,700
| +216% | +$5.84M |
|
887
CALL
Universal Display
OLED
$3.71B
| $10.7M | 0.02% |
82,900
+2,100
| +3% | +$254K |
|
888
CALL
Abbott
ABT
$180B
| $10.7M | 0.02% |
200,000
-111,400
| -36% | -$5.59M |
|
889
Puma Biotechnology
PBYI
$406M
| $10.6M | 0.02% |
88,911
-111,257
| -56% | -$10.3M |
|
890
CALL
Nike
NKE
$61.9B
| $10.6M | 0.02% |
205,200
-10,800
| -5% | -$606K |
|
|
BBBY
891
Bed Bath & Beyond
BBBY
$473M
| $10.6M | 0.02% |
475,982
-13,865
| -3% | -$209K |
|
892
PUT
Walmart Inc
WMT
$871B
| $10.6M | 0.02% |
407,400
-171,600
| -30% | -$4.5M |
|
893
Capri Holdings
CPRI
$1.77B
| $10.6M | 0.02% |
221,580
+122,174
| +123% | +$4.96M |
|
|
AY
894
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $10.6M | 0.02% |
536,269
-12,212
| -2% | -$254K |
|
895
PUT
Diageo
DEO
$46.2B
| $10.6M | 0.02% |
79,900
+10,000
| +14% | +$1.29M |
|
896
Oceaneering
OII
$5.25B
| $10.5M | 0.02% |
399,839
-93,078
| -19% | -$2.25M |
|
|
EGOV
897
DELISTED
NIC Inc
EGOV
| $10.5M | 0.02% |
610,566
-76,041
| -11% | -$1.29M |
|
|
AVP
898
DELISTED
Avon Products, Inc.
AVP
| $10.5M | 0.02% |
4,492,469
+614,800
| +16% | +$1.82M |
|
899
AutoZone
AZO
$48.3B
| $10.5M | 0.02% |
17,581
-34,510
| -66% | -$18.4M |
|
900
Photronics
PLAB
$1.79B
| $10.5M | 0.02% |
1,181,352
+122,598
| +12% | +$1.09M |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.